In journal article: "syngeneic hematopoietic stem cell transplantation after mobilization failure in an adolescent with intracranial germ cell tumor", by sánchez-sierra, n.Et al it was reported that the patient received hdct based on siop-cns-gct-ii guidelines and a non-manipulated syngeneic graft.Given the cellularity of the product (2.4 × 106 cd34+/kg), he received subcutaneous g-csf from day+5 to 2 days after reaching the white blood cell graft (day+9) as well as corticosteroid prophylaxis of the engraftment syndrome.As main complications, he developed escherichia coli sepsis, grade 3 hyperemesis, and mucositis.Antiviral and antibiotic prophylaxis was discontinued 4 months after shsct.The patient continued treatment as planned with focal proton beam radiation therapy.He ended treatment 8 months after diagnosis and is currently in complete remission.Patient id and weight are not available at this time as they were not included in the article for this event.The disposable set is not available for return because it was discarded by the customer.
|
Lot number and expiry information were not included in the article and are not available.Investigation is in process, a follow-up report will be provided.Citation: sánchez-sierra, n., perez-somarriba, m., santa-maria, v., cruz, o., garcía-rey, e., martorell, l., rovira, m., margarit, a., & marsal, j.(2023).Syngeneic hematopoietic stem cell transplantation after mobilization failure in an adolescent with intracranial germ cell tumor.Pediatric blood & cancer, 70(5).Https://doi.Org/10.1002/pbc.30177.
|